This application is a competitive renewal of the UCLA Center for Advancing Longitudinal Drug Abuse Research (CALDAR;P30DA016383) funded by NIDA since September 2005. The overarching mission of CALDAR is to promote and support rigorous longitudinal research to enhance scientific understanding of how drug use patterns evolve and interplay with HIV, drug treatment services, and other service systems (e.g., criminal justice, mental health) over time. Building upon the life course drug use framework and considerable empirical examinations of drug use trajectories and related HIV risk, mental health, and criminal involvement, during this renewal period the Center's theme will focus on recovery from drug dependence. To support the Center's mission, thematic focus on recovery, and research projects, CALDAR comprises three Cores: (1) the Coordination &Integration Core will provide overall Center leadership, administrative support, coordination across Cores, and support for the pilot project program;(2) the Research &Methods Support Core will identify priorities for longitudinal research on drug abuse and recovery and will enhance the quality of attendant methodological procedures and approaches;and (3) the Statistical Support &Analysis Core will support longitudinal statistical applications and analyses. All Cores will be involved in CALDAR's education, mentoring, and training activities. The chronic nature of drug dependence necessitates a longitudinal approach to better understand and address addiction and to promote recovery. Given the complexity of conducting quality longitudinal studies, the rapid development of longitudinal statistical modeling techniques, and the challenges in analyzing longitudinal data, the Center's infrastructure greatly enhances the efficiency and quality of Center-affiliated projects, resulting in enhanced capacity to conduct and integrate longitudinal research projects and address recovery-related issues. CALDAR serves a crucial role as a national resource for advancing longitudinal research on drug abuse and recovery via its scientific findings and dissemination, data sharing, education and training, and support of emerging investigators.
The overarching mission of CALDAR is to promote and support rigorous longitudinal research to enhance scientific understanding of how drug use patterns evolve and interplay with HIV, drug treatment services, and other service systems (e.g., criminal justice, mental health) over time. Findings of the Center have clinical and policy implications for developing and applying strategies to address drug addiction and to promote recovery, as well as related issues in HIV, mental health, and criminality.
|Li, Ming D; Hser, Yih-Ing; Chen, Zhiwei et al. (2016) Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia. J Neuroimmune Pharmacol 11:379-82|
|Hser, Yih-Ing; Huang, David; Saxon, Andrew J et al. (2016) Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphineâ€Š+â€ŠNaloxone and Methadone. J Addict Med :|
|Schulte, Marya; Liang, Di; Wu, Fei et al. (2016) A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USA. J Neuroimmune Pharmacol 11:511-22|
|Farabee, David; Schulte, Marya; Gonzales, Rachel et al. (2016) Technological aids for improving longitudinal research on substance use disorders. BMC Health Serv Res 16:370|
|Han, Yun; Lin, Veronique; Wu, Fei et al. (2016) Gender Comparisons Among Asian American and Pacific Islander Patients in Drug Dependency Treatment. Subst Use Misuse 51:752-62|
|Krebs, Emanuel; Urada, Darren; Evans, Elizabeth et al. (2016) The costs of crime during and after publicly-funded treatment for opioid use disorders: a population-level study for the state of California. Addiction :|
|Saxena, Preeta; Grella, Christine E; Messina, Nena P (2016) Continuing Care and Trauma in Women Offenders' Substance Use, Psychiatric Status, and Self-Efficacy Outcomes. Women Crim Justice 26:99-121|
|Hser, Yih-Ing; Evans, Elizabeth; Huang, David et al. (2016) Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction 111:695-705|
|McPherson, Sterling; Barbosa-Leiker, Celestina; Mamey, Mary Rose et al. (2015) A 'missing not at random' (MNAR) and 'missing at random' (MAR) growth model comparison with a buprenorphine/naloxone clinical trial. Addiction 110:51-8|
|Evans, Elizabeth; Padwa, Howard; Li, Libo et al. (2015) Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment. J Subst Abuse Treat 59:10-9|
Showing the most recent 10 out of 147 publications